Last reviewed · How we verify
Lidocaine-Sodium Bicarbonate
At a glance
| Generic name | Lidocaine-Sodium Bicarbonate |
|---|---|
| Also known as | Buffered paracervical anesthesia |
| Sponsor | University of Hawaii |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Bladder Directed vs. Pelvic Floor Therapy in IC/BPS (PHASE2)
- Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia
- Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial (PHASE1, PHASE2)
- The Effect of Local Anesthesia Techniques on Postoperative Pain After Laser Treatment of Pilonidal Sinus (NA)
- Split Face Study of the Duration of Local Anesthetics - Fourth Arm (PHASE4)
- WALANT Versus Local Anesthesia in Central Venous Catheter Insertion (NA)
- Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery (PHASE3)
- The Effectiveness of Intracuff Dexmedetomidine in Preventing Postoperative Sore Throat Following Prone Surgery (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lidocaine-Sodium Bicarbonate CI brief — competitive landscape report
- Lidocaine-Sodium Bicarbonate updates RSS · CI watch RSS
- University of Hawaii portfolio CI